{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:33:18Z","timestamp":1708648398549},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,21]]},"DOI":"10.7759\/cureus.54653","type":"journal-article","created":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T03:58:11Z","timestamp":1708574291000},"source":"Crossref","is-referenced-by-count":0,"title":["Determining the Association Between the Origin of Sepsis and the Severity of Sepsis in Intensive Care Unit (ICU) Patients Using Acute Physiology and Chronic Health Evaluation (APACHE) IV"],"prefix":"10.7759","author":[{"given":"Antony J","family":"Arumairaj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imnett","family":"Habtes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hansang","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio C","family":"Valencia-Manrique","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Arzu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Mattana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shobhana","family":"Chaudhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natoushka","family":"Trenard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Newman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (sepsis-3)","volume":"315","author":"Singer M","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, et al.. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016, 315:801-10. 10.1001\/jama.2016.0287","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2017.05.019","article-title":"The characteristics and impact of source of infection on sepsis-related ICU outcomes","volume":"41","author":"Jeganathan N","year":"2017","unstructured":"Jeganathan N, Yau S, Ahuja N, Otu D, Stein B, Fogg L, Balk R. The characteristics and impact of source of infection on sepsis-related ICU outcomes. J Crit Care. 2017, 41:170-6. 10.1016\/j.jcrc.2017.05.019","journal-title":"J Crit Care"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd KE","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, et al.. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet. 2020, 395:200-11. 10.1016\/S0140-6736(19)32989-7","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000003342","article-title":"Epidemiology and costs of sepsis in the United States-an analysis based on timing of diagnosis and severity level","volume":"46","author":"Paoli CJ","year":"2018","unstructured":"Paoli CJ, Reynolds MA, Sinha M, Gitlin M, Crouser E. Epidemiology and costs of sepsis in the United States-an analysis based on timing of diagnosis and severity level. Crit Care Med. 2018, 46:1889-97. 10.1097\/CCM.0000000000003342","journal-title":"Crit Care Med"},{"key":"ref5","article-title":"National inpatient hospital costs: the most expensive conditions by Payer, 2013","author":"Torio CM","year":"2006","unstructured":"Torio CM, Moore BJ. National inpatient hospital costs: the most expensive conditions by Payer, 2013. 2006,"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31827e83af","article-title":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012","volume":"41","author":"Dellinger RP","year":"2013","unstructured":"Dellinger RP, Levy MM, Rhodes A, et al.. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013, 41:580-637. 10.1097\/CCM.0b013e31827e83af","journal-title":"Crit Care Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31827c09f8","article-title":"Benchmarking the incidence and mortality of severe sepsis in the United States","volume":"41","author":"Gaieski DF","year":"2013","unstructured":"Gaieski DF, Edwards JM, Kallan MJ, Carr BG. Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med. 2013, 41:1167-74. 10.1097\/CCM.0b013e31827c09f8","journal-title":"Crit Care Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1553","article-title":"Long-term cognitive impairment and functional disability among survivors of severe sepsis","volume":"304","author":"Iwashyna TJ","year":"2010","unstructured":"Iwashyna TJ, Ely EW, Smith DM, Langa KM. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. 2010, 304:1787-94. 10.1001\/jama.2010.1553","journal-title":"JAMA"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1312359","article-title":"Severe sepsis and septic shock","volume":"369","author":"Moreira J","year":"2013","unstructured":"Moreira J. Severe sepsis and septic shock. N Engl J Med. 2013, 369:2063. 10.1056\/NEJMc1312359","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-021-06574-0","article-title":"Source-specific host response and outcomes in critically ill patients with sepsis: a prospective cohort study","volume":"48","author":"Peters-Sengers H","year":"2022","unstructured":"Peters-Sengers H, Butler JM, Uhel F, et al.. Source-specific host response and outcomes in critically ill patients with sepsis: a prospective cohort study. Intensive Care Med. 2022, 48:92-102. 10.1007\/s00134-021-06574-0","journal-title":"Intensive Care Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201310-1875OC","article-title":"Association between source of infection and hospital mortality in patients who have septic shock","volume":"189","author":"Leligdowicz A","year":"2014","unstructured":"Leligdowicz A, Dodek PM, Norena M, Wong H, Kumar A, Kumar A. Association between source of infection and hospital mortality in patients who have septic shock. Am J Respir Crit Care Med. 2014, 189:1204-13. 10.1164\/rccm.201310-1875OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.915224","article-title":"In-hospital mortality of sepsis differs depending on the origin of infection: an investigation of predisposing factors","volume":"9","author":"Pieroni M","year":"2022","unstructured":"Pieroni M, Olier I, Ortega-Martorell S, Johnston BW, Welters ID. In-hospital mortality of sepsis differs depending on the origin of infection: an investigation of predisposing factors. Front Med (Lausanne). 2022, 9:915224. 10.3389\/fmed.2022.915224","journal-title":"Front Med (Lausanne)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000215112.84523.F0","article-title":"Acute Physiology and Chronic Health Evaluation (APACHE) IV: hospital mortality assessment for today's critically ill patients","volume":"34","author":"Zimmerman JE","year":"2006","unstructured":"Zimmerman JE, Kramer AA, McNair DS, Malila FM. Acute Physiology and Chronic Health Evaluation (APACHE) IV: hospital mortality assessment for today's critically ill patients. Crit Care Med. 2006, 34:1297-310. 10.1097\/01.CCM.0000215112.84523.F0","journal-title":"Crit Care Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/0970-9185.209741","article-title":"Comparison of acute physiology and chronic health evaluation II (APACHE II) and acute physiology and chronic health evaluation IV (APACHE IV) severity of illness scoring systems, in a multidisciplinary ICU","volume":"33","author":"Varghese YE","year":"2017","unstructured":"Varghese YE, Kalaiselvan MS, Renuka MK, Arunkumar AS. Comparison of acute physiology and chronic health evaluation II (APACHE II) and acute physiology and chronic health evaluation IV (APACHE IV) severity of illness scoring systems, in a multidisciplinary ICU. J Anaesthesiol Clin Pharmacol. 2017, 33:248-53. 10.4103\/0970-9185.209741","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-019-0383-3","article-title":"Variations in infection sites and mortality rates among patients in intensive care units with severe sepsis and septic shock in Japan","volume":"7","author":"Abe T","year":"2019","unstructured":"Abe T, Ogura H, Kushimoto S, et al.. Variations in infection sites and mortality rates among patients in intensive care units with severe sepsis and septic shock in Japan. J Intensive Care. 2019, 7:28. 10.1186\/s40560-019-0383-3","journal-title":"J Intensive Care"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-02917-3","article-title":"Phenotypic heterogeneity by site of infection in surgical sepsis: a prospective longitudinal study","volume":"24","author":"Stortz JA","year":"2020","unstructured":"Stortz JA, Cox MC, Hawkins RB, et al.. Phenotypic heterogeneity by site of infection in surgical sepsis: a prospective longitudinal study. Crit Care. 2020, 24:203. 10.1186\/s13054-020-02917-3","journal-title":"Crit Care"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/0885066615627778","article-title":"Does infection site matter? A systematic review of infection site mortality in sepsis","volume":"32","author":"Motzkus CA","year":"2017","unstructured":"Motzkus CA, Luckmann R. Does infection site matter? A systematic review of infection site mortality in sepsis. J Intensive Care Med. 2017, 32:473-9. 10.1177\/0885066615627778","journal-title":"J Intensive Care Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1829","article-title":"Immunosuppression in patients who die of sepsis and multiple organ failure","volume":"306","author":"Boomer JS","year":"2011","unstructured":"Boomer JS, To K, Chang KC, et al.. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA. 2011, 306:2594-605. 10.1001\/jama.2011.1829","journal-title":"JAMA"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70001-X","article-title":"Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach","volume":"13","author":"Hotchkiss RS","year":"2013","unstructured":"Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis. 2013, 13:260-8. 10.1016\/S1473-3099(13)70001-X","journal-title":"Lancet Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4161\/viru.26913","article-title":"An alternate pathophysiologic paradigm of sepsis and septic shock: implications for optimizing antimicrobial therapy","volume":"5","author":"Kumar A","year":"2014","unstructured":"Kumar A. An alternate pathophysiologic paradigm of sepsis and septic shock: implications for optimizing antimicrobial therapy. Virulence. 2014, 5:80-97. 10.4161\/viru.26913","journal-title":"Virulence"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e318232db65","article-title":"Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007","volume":"40","author":"Lagu T","year":"2012","unstructured":"Lagu T, Rothberg MB, Shieh MS, Pekow PS, Steingrub JS, Lindenauer PK. Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit Care Med. 2012, 40:754-61. 10.1097\/CCM.0b013e318232db65","journal-title":"Crit Care Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/s0891-5520(05)70083-0","article-title":"Cytokines and anticytokines in the pathogenesis of sepsis","volume":"13","author":"van der Poll T","year":"1999","unstructured":"van der Poll T, van Deventer SJ. Cytokines and anticytokines in the pathogenesis of sepsis. Infect Dis Clin North Am. 1999, 13:413-426. 10.1016\/s0891-5520(05)70083-0","journal-title":"Infect Dis Clin North Am"},{"key":"ref23","doi-asserted-by":"crossref","DOI":"10.1177\/09680519010070040301","article-title":"Coagulation and inflammation","volume":"7","author":"van der Poll T","year":"2001","unstructured":"van der Poll T. Coagulation and inflammation. J Endotoxin Res. 2001, 7:301-4.","journal-title":"J Endotoxin Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock","volume":"34","author":"Kumar A","year":"2006","unstructured":"Kumar A, Roberts D, Wood KE, et al.. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006, 34:1589-96. 10.1097\/01.CCM.0000217961.75225.E9","journal-title":"Crit Care Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa010307","article-title":"Early goal-directed therapy in the treatment of severe sepsis and septic shock","volume":"345","author":"Rivers E","year":"2001","unstructured":"Rivers E, Nguyen B, Havstad S, et al.. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001, 345:1368-77. 10.1056\/NEJMoa010307","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-0352","article-title":"Nationwide trends of severe sepsis in the 21st century (2000-2007)","volume":"140","author":"Kumar G","year":"2011","unstructured":"Kumar G, Kumar N, Taneja A, et al.. Nationwide trends of severe sepsis in the 21st century (2000-2007). Chest. 2011, 140:1223-31. 10.1378\/chest.11-0352","journal-title":"Chest"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201211-2020OC","article-title":"Recombinant human activated protein C for adults with septic shock: a randomized controlled trial","volume":"187","author":"Annane D","year":"2013","unstructured":"Annane D, Timsit JF, Megarbane B, et al.. Recombinant human activated protein C for adults with septic shock: a randomized controlled trial. Am J Respir Crit Care Med. 2013, 187:1091-7. 10.1164\/rccm.201211-2020OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"De Backer D","year":"2010","unstructured":"De Backer D, Biston P, Devriendt J, et al.. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010, 362:779-89. 10.1056\/NEJMoa0907118","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1204242","article-title":"Hydroxyethyl starch 130\/0.42 versus Ringer's acetate in severe sepsis","volume":"367","author":"Perner A","year":"2012","unstructured":"Perner A, Haase N, Guttormsen AB, et al.. Hydroxyethyl starch 130\/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med. 2012, 367:124-34. 10.1056\/NEJMoa1204242","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-11-85","article-title":"Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal","volume":"11","author":"Kent DM","year":"2010","unstructured":"Kent DM, Rothwell PM, Ioannidis JP, Altman DG, Hayward RA. Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal. Trials. 2010, 11:85. 10.1186\/1745-6215-11-85","journal-title":"Trials"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/218624-determining-the-association-between-the-origin-of-sepsis-and-the-severity-of-sepsis-in-intensive-care-unit-icu-patients-using-acute-physiology-and-chronic-health-evaluation-apache-iv","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T03:58:15Z","timestamp":1708574295000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/218624-determining-the-association-between-the-origin-of-sepsis-and-the-severity-of-sepsis-in-intensive-care-unit-icu-patients-using-acute-physiology-and-chronic-health-evaluation-apache-iv"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,21]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.54653","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,21]]}}}